CLINDAMYCIN Drug Patent Profile
✉ Email this page to a colleague
When do Clindamycin patents expire, and what generic alternatives are available?
Clindamycin is a drug marketed by Aurobindo Pharma, Chartwell Molecular, Cosette, Epic Pharma Llc, Glenmark Pharms Ltd, Micro Labs, Pharmobedient, Sun Pharm Inds Ltd, Teva, Watson Labs, Zydus Pharms Usa, Amneal Pharms, Aurobindo Pharma Ltd, Chartwell Rx, Extrovis, Padagis Us, Rising, Somerset Theraps Llc, Padagis Israel, Taro, Fougera Pharms, Alembic, Amneal, Encube, Solaris Pharma Corp, Sun Pharma Canada, Zydus Lifesciences, Abraxis Pharm, Almaject, Bedford, Bristol Myers Squibb, Fresenius Kabi Usa, Hikma, Igi Labs Inc, Loch, Marsam Pharms Llc, Sagent Pharms Inc, Solopak, Teva Parenteral, Boca Pharma Llc, Encube Ethicals, Fougera Pharms Inc, G And W Labs Inc, Ingenus Pharms Llc, Pai Holdings Pharm, Ph Health, Taro Pharm Inds, Vintage Pharms, Xttrium Labs Inc, Carnegie, Actavis Labs Ut Inc, Glenmark Speclt, Mylan Pharms Inc, Zydus Pharms, Actavis Mid Atlantic, Baxter Hlthcare Corp, Sandoz Inc, Abbott Labs, and Baxter Hlthcare. and is included in one hundred and eleven NDAs.
The generic ingredient in CLINDAMYCIN is clindamycin phosphate; tretinoin. There are fifty-five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clindamycin
A generic version of CLINDAMYCIN was approved as clindamycin phosphate; tretinoin by ACTAVIS MID ATLANTIC on June 12th, 2015.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CLINDAMYCIN?
- What are the global sales for CLINDAMYCIN?
- What is Average Wholesale Price for CLINDAMYCIN?
Summary for CLINDAMYCIN
| US Patents: | 0 |
| Applicants: | 59 |
| NDAs: | 111 |
| Drug Prices: | Drug price information for CLINDAMYCIN |
| Drug Sales Revenues: | Drug sales revenues for CLINDAMYCIN |
| DailyMed Link: | CLINDAMYCIN at DailyMed |
